EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Renal Medullary Carcinoma: Establishing Standards in Practice

Kathryn E Beckermann, Deva Sharma, Shruti Chaturvedi, Pavlos Msaouel, Miguel R Abboud, Yves Allory, Franck Bourdeaut, Julien Calderaro, Aguirre A de Cubas, Vimal K Derebail, Andrew L Hong, Rakhi P Naik und 10 weitere

Journal of Oncology Practice · 2017-07 · 13 (7) · 414-421

DOI: 10.1200/jop.2017.020909 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Oncology Practice, 2017-07. Verfasst von Kathryn E Beckermann und 21 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University Medical Center, Nashville; St Jude Children's Research Hospital, Memphis, TN; University of Texas MD Anderson Cancer Center; Ba…. Hauptthemen laut MEDLINE: Carcinoma, Medullary, Kidney Neoplasms, Practice Guidelines as Topic. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although renal medullary carcinoma (RMC) is a rare subtype of kidney cancer, it is particularly devastating in that it is nearly uniformly lethal. No established guidelines exist for the diagnosis and management of RMC. In April 2016, a panel of experts developed clinical guidelines on the basis of a literature review and consensus statements. The goal was to propose recommendations for standardized diagnostic and management approaches and to establish an international clinical registry and biorepository for RMC. Published data are limited to case reports and small retrospective reviews. The RMC Working Group prepared recommendations to inform providers and patients faced with a low level of medical evidence. The diagnosis of RMC should be considered in all patients younger than 50 years with poorly differentiated carcinoma that arises from the renal medulla. These patients should be tested for sickle cell hemoglobinopathies, and if positive, SMARCB1/INI1 loss should be confirmed by immunohistochemistry. The majority of patients with RMC are diagnosed with metastatic disease. Upfront radical nephrectomy should be considered in patients with good performance status and low metastatic burden or after response to systemic therapy. Currently, cytotoxic, platinum-based chemotherapy provides the best, albeit brief, palliative clinical benefit. Vascular endothelial growth factor–directed therapies and mammalian target of rapamycin inhibitors are ineffective in RMC as monotherapy. Therapeutic trials of novel agents are now available for RMC, and every effort should be made to enroll patients in clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, MedullaryKidney NeoplasmsPractice Guidelines as TopicAnemia, Sickle CellHumansRegistries

Autor:innen und Institutionen

  • Vanderbilt University Medical Center, Nashville; St Jude Children's Research Hospital, Memphis, TN; University of Texas MD Anderson Cancer Center; Baylor College of Medicine, Houston, TX; American University of Beirut M…

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS

Zitieren

APA

Beckermann, K. E., Sharma, D., Chaturvedi, S., Msaouel, P., Abboud, M. R., Allory, Y., Bourdeaut, F., Calderaro, J., de Cubas, A. A., Derebail, V. K., Hong, A. L., Naik, R. P., Malouf, G. G., Mullen, E. A., Reuter, V. E., Roberts, C. W. M., Walker, C. L., Wood, C. G., DeBaun, M. R., …, & Rathmell, W. K. (2017). Renal Medullary Carcinoma: Establishing Standards in Practice. Journal of Oncology Practice, 13(7), 414-421. https://doi.org/10.1200/jop.2017.020909

Vancouver

Beckermann KE, Sharma D, Chaturvedi S, Msaouel P, Abboud MR, Allory Y, et al. Renal Medullary Carcinoma: Establishing Standards in Practice. Journal of Oncology Practice. 2017;13(7):414-421. doi:10.1200/jop.2017.020909

BibTeX
@article{Beckermann2017,
  author = {Beckermann, Kathryn E and Sharma, Deva and Chaturvedi, Shruti and Msaouel, Pavlos and Abboud, Miguel R and Allory, Yves and Bourdeaut, Franck and Calderaro, Julien and de Cubas, Aguirre A and Derebail, Vimal K and Hong, Andrew L and Naik, Rakhi P and Malouf, Gabriel G and Mullen, Elizabeth A and Reuter, Victor E and Roberts, Charles W M and Walker, Cheryl L and Wood, Christopher G and DeBaun, Michael R and Van Poppel, Hendrik and Tannir, Nizar M and Rathmell, W Kimryn},
  title = {Renal Medullary Carcinoma: Establishing Standards in Practice},
  journal = {Journal of Oncology Practice},
  year = {2017},
  volume = {13},
  number = {7},
  pages = {414--421},
  doi = {10.1200/jop.2017.020909}
}
Kostenlos starten →